Bill Arrowsmith takes over for Bryan Wolcott, who retired from the position at the end of last year.
Restek Corporation, a provider of chromatography consumables, has announced the retirement of Bryan Wolcott, president and CEO, on December 31, 2023. With over 26 years of dedicated service, Wolcott served as Restek’s chief executive starting back in 2010, according to a press release from the company. He will remain a member of Restek’s Board of Directors.
Bill Arrowsmith will take over as the company’s CEO. Arrowsmith joined Restek back in 2017, when he served as the company’s chief financial officer before taking on the role of general manager in January 2023. As chief executive, Arrowsmith will be tasked with driving Restek's growth and development.
Prior to joining Restek, Arrowsmith held various finance and general management positions with companies such as Ernst & Young, AMETEK, and PwC. He holds a BS degree in accounting and international business from Pennsylvania State University and an MBA from Cornell University.
Restek is headquartered in Bellefonte, Pennsylvania. Founded in 1985, it has established officers in Japan, Germany, China, France, Italy, and United Kingdom. Restek is a provider of manufacturing and distributing high-quality instrument consumables, chromatography columns, sample preparation materials, scientific supplies, and reference standards.
This article was written with the help of artificial intelligence and has been edited to ensure accuracy and clarity. You can read more about our policy for using AI here.
Liquid Chromatography to Analyze Vitamin D Proteins in Psoriasis Patients
January 21st 2025Can a protein involved in delivering Vitamin D to target tissues have an altered serum profile in psoriasis patients with cardiovascular disease? Researchers used liquid chromatography (LC) to help find out.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.